Jones D P, Binnie C D, Bown R L, Lloyd D S, Watson B W
Electroencephalogr Clin Neurophysiol. 1976 Jun;40(6):661-5. doi: 10.1016/0013-4694(76)90141-3.
Early diagnosis of chronic hepatic encephalopathy (CHE) in the latent stage before the appearance of clinical signs, should reduce both morbidity and mortality as deterioration is often preventable by treatment. Since existing diagnostic procedures are inadequate, we have investigated a test in which morphine is used as a provocative agent and any resulting change in cerebral function assessed by measurement of the CNV in conjuction with a psychological trail test. Twenty six patients were studied, 6 of whom had clinically overt CHE. A significant correlation (P less than 0.05) between the change in CNV amplitude with morphine and the initial CNV amplitude, consistent with the theoretical model of Tecce (1972), was found. However, the CNV and trail test results taken as a whole did not allow even those patients with overt CHE to be distinguished and we conclude that it is unlikely that differing degrees of latent CHE could be detected.
在慢性肝性脑病(CHE)出现临床体征之前的潜伏期进行早期诊断,由于病情恶化通常可通过治疗预防,因此应能降低发病率和死亡率。由于现有的诊断方法并不完善,我们研究了一种检测方法,其中使用吗啡作为激发剂,并通过测量伴随心理追踪测试的关联性负变(CNV)来评估由此产生的脑功能变化。我们对26名患者进行了研究,其中6名患有临床显性CHE。发现吗啡引起的CNV幅度变化与初始CNV幅度之间存在显著相关性(P小于0.05),这与特切(1972年)的理论模型一致。然而,总体的CNV和追踪测试结果甚至无法区分那些显性CHE患者,我们得出结论,不太可能检测出不同程度的潜在CHE。